Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03.
- DOI
- 10.1007/s10549-018-4873-0
- Published
- 2018 Oct
- Container
- Breast cancer research and treatment
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10549-018-4873-0,
title = {Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03.},
author = {Sagara Y and Takada M and Ohi Y and Ohtani S and Kurozumi S and Inoue K and Kosaka Y and Hattori M and Yamashita T and Takao S and Sato N and Iwata H and Kurosumi M and Toi M},
year = {2018},
journal = {Breast cancer research and treatment},
doi = {10.1007/s10549-018-4873-0},
url = {https://doi.org/10.1007/s10549-018-4873-0}
}RIS
TY - JOUR TI - Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03. AU - Sagara Y AU - Takada M AU - Ohi Y AU - Ohtani S AU - Kurozumi S AU - Inoue K AU - Kosaka Y AU - Hattori M AU - Yamashita T AU - Takao S AU - Sato N AU - Iwata H AU - Kurosumi M AU - Toi M PY - 2018 JO - Breast cancer research and treatment DO - 10.1007/s10549-018-4873-0 UR - https://doi.org/10.1007/s10549-018-4873-0 ER -
APA
Y, S., M, T., Y, O., S, O., S, K., K, I., Y, K., M, H., T, Y., S, T., N, S., H, I., M, K., & M, T. (2018). Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03.. Breast cancer research and treatment. https://doi.org/10.1007/s10549-018-4873-0
Source records
- pubmed · retrieved 2026-09-26T07:53:02.586Z